Atlas Trials

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial

Clinical trial NCT03699904 · TERMINATED

Trial details

NCT number
NCT03699904
Sponsor
Belfast Health and Social Care Trust
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COPDEBV
Start date
2018-10-11
Primary completion
2020-05-07
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.